Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04232098 · ClinicalTrials.gov registry record · NA
Effect of Feet and Calf Heating on Glucose Tolerance
A NA study, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04232098: Completed NA study, sponsored by San Diego State University.
NCT04232098 is a NA study that has completed, run by San Diego State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04232098, a NA study, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Determine the effect of feet and calf heating on glucose tolerance relative to thermoneutral control. Heat will be administered using hot water (40 degrees celsius).
Interventions
- OTHER Heat to ankle
- OTHER Heat to calf
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2021-02-01 |
| Phase | NA |
What the finished NCT04232098 record still lists
NCT04232098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Heat to ankle is the first listed.
NCT04232098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04232098 about?
NCT04232098 is a clinical study titled "Effect of Feet and Calf Heating on Glucose Tolerance". Determine the effect of feet and calf heating on glucose tolerance relative to thermoneutral control. Heat will be administered using hot water (40 degrees celsius).
What is the current status of trial NCT04232098?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-02-01. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT04232098?
The interventions under investigation include: Heat to ankle (OTHER), Heat to calf (OTHER).
Who is sponsoring clinical trial NCT04232098?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04232098's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI